162 related articles for article (PubMed ID: 36266327)
21. Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms.
Baranwal A; Hahn CN; Shah MV; Hiwase DK
Curr Hematol Malig Rep; 2022 Dec; 17(6):254-265. PubMed ID: 35986863
[TBL] [Abstract][Full Text] [Related]
22. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
Becktell K; Berlyne D; Pagliuca S; Pommert L; Prata PH; Margolis D; de Latour RP; Dufour C; Pierri F
Leuk Res; 2019 May; 80():19-25. PubMed ID: 30908982
[TBL] [Abstract][Full Text] [Related]
23. Germline genetic factors in the pathogenesis of myeloproliferative neoplasms.
Bellanné-Chantelot C; Rabadan Moraes G; Schmaltz-Panneau B; Marty C; Vainchenker W; Plo I
Blood Rev; 2020 Jul; 42():100710. PubMed ID: 32532454
[TBL] [Abstract][Full Text] [Related]
24. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
[TBL] [Abstract][Full Text] [Related]
25. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
Carraway HE; LaFramboise T
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
[TBL] [Abstract][Full Text] [Related]
26. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
[TBL] [Abstract][Full Text] [Related]
27. Pediatric Germline Predisposition to Myeloid Neoplasms.
Thompson C; Ariagno S; Kohorst MA
Curr Hematol Malig Rep; 2022 Dec; 17(6):266-274. PubMed ID: 36117229
[TBL] [Abstract][Full Text] [Related]
28. Strategy for identification of a potential inherited leukemia predisposition in a 299 patient's cohort with tumor-only sequencing data.
Aguilera-Diaz A; Larrayoz MJ; Palomino-Echeverría S; Vazquez I; Ariceta B; Mañú A; Blasco-Iturri Z; Bernal Del Castillo T; Olivares Salaverri M; Olave Rubio MT; Rifon-Roca J; Alfonso-Pierola A; Prosper F; Fernandez-Mercado M; Calasanz MJ
Leuk Res; 2020 Aug; 95():106386. PubMed ID: 32512379
[TBL] [Abstract][Full Text] [Related]
29. [Bone marrow failure and TP53 activating mutations].
Ito E
Rinsho Ketsueki; 2022; 63(9):1115-1125. PubMed ID: 36198537
[TBL] [Abstract][Full Text] [Related]
30. Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms.
Kongkiatkamon S; Terkawi L; Guan Y; Adema V; Hasipek M; Dombrovski T; Co M; Walter W; Awada H; Parker Y; Hutter S; Pagliuca S; Gurnari C; Rogers HJ; Meggendorfer M; Lindner DJ; Haferlach T; Visconte V; LaFramboise T; Jha BK; Maciejewski JP
Leukemia; 2022 Aug; 36(8):2086-2096. PubMed ID: 35761024
[TBL] [Abstract][Full Text] [Related]
31. Individualized risks of first adverse events in patients with Fanconi anemia.
Rosenberg PS; Huang Y; Alter BP
Blood; 2004 Jul; 104(2):350-5. PubMed ID: 15059844
[TBL] [Abstract][Full Text] [Related]
32. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
Galera P; Dulau-Florea A; Calvo KR
Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
[TBL] [Abstract][Full Text] [Related]
33. Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma.
Bu L; Hameed NUF; Luo C; Hong P; Zhou X; Wang S; Wu S
J Neurooncol; 2021 Mar; 152(1):27-36. PubMed ID: 33486679
[TBL] [Abstract][Full Text] [Related]
34. Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1.
Guo Y; Kartawinata M; Li J; Pickett HA; Teo J; Kilo T; Barbaro PM; Keating B; Chen Y; Tian L; Al-Odaib A; Reddel RR; Christodoulou J; Xu X; Hakonarson H; Bryan TM
Blood; 2014 Oct; 124(18):2767-74. PubMed ID: 25205116
[TBL] [Abstract][Full Text] [Related]
35. Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype.
Chasseloup F; Pankratz N; Lane J; Faucz FR; Keil MF; Chittiboina P; Kay DM; Hussein Tayeb T; Stratakis CA; Mills JL; Hernández-Ramírez LC
J Clin Endocrinol Metab; 2020 Jun; 105(6):1983-2005. PubMed ID: 32232325
[TBL] [Abstract][Full Text] [Related]
36. Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer.
Yehia L; Niazi F; Ni Y; Ngeow J; Sankunny M; Liu Z; Wei W; Mester JL; Keri RA; Zhang B; Eng C
Am J Hum Genet; 2015 Nov; 97(5):661-76. PubMed ID: 26522472
[TBL] [Abstract][Full Text] [Related]
37. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
[TBL] [Abstract][Full Text] [Related]
38. Cancer predisposition and germline CTNNA1 variants.
Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
[TBL] [Abstract][Full Text] [Related]
40. Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study.
Shen Y; Liu Q; Li H; Liu W; Hu H; Zhao Y; Li Y; Chen Y; Liu S; Yu Q; Zhuang H; Wu L; Hu Z; Zheng Z; Shen J; Lin S; Shen Y; Zhou Y; Ye B; Wu D
Ann Hematol; 2023 Mar; 102(3):503-517. PubMed ID: 36622392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
